China Medical System Overview

  • Status
  • Public
  • Employees
  • 4,372
  • Stock Symbol
  • 00867
Stock Symbol
  • Investments
  • 10
  • Share Price
  • $2.18
  • (As of Tuesday Closing)

China Medical System General Information


China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Devices and Supplies
Stock Exchange
Primary Office
  • No.11 Langshan Road
  • 6th Floor & 8th Floor, Building A Tongfang Information Harbour, Hi-tech Industrial Park North, Nansh
  • Shenzhen, 518057
  • China
+86 0755 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

China Medical System Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.18 $2.24 $0.95 - $2.50 $5.4B 2.47B 11.3M $0.15

China Medical System Financials Summary

In Thousands,
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,576,650 2,576,650 3,551,522 2,413,214
Revenue 1,005,407 1,005,407 879,007 821,348
EBITDA 432,923 432,923 391,628 340,300
Net Income 366,267 366,267 283,765 279,638
Total Assets 1,944,051 1,944,051 1,596,584 1,527,323
Total Debt 91,861 91,861 102,016 212,995
Public Fundamental Data provided by Morningstar, Inc. disclaimer

China Medical System Executive Team (3)

Name Title Board Seat Contact Info
Lam Kong Chief Executive Officer, Chairman, Member of the Nomination Committee and Executive Director
Chen Yanling Chief Financial Officer, Vice-President, Chairman of the Environmental, Social and Governance Committee, Board Member & Executive Director
Chen Hongbing Chief Operating Officer, Vice President, Board Member & Executive Director
To view China Medical System’s complete executive team members history, request access »

China Medical System Board Members (1)

Name Representing Role Since
000 0000 China Medical System Chief Executive Officer, Chairman, Member of the Nomination Committee and Executive Director 000 0000
To view China Medical System’s complete board members history, request access »

China Medical System Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

China Medical System Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 25-Apr-2021 00000 00000 00 000.00 Biotechnology
0000 0000000000000 05-Feb-2021 000000000000000000 Pharmaceuticals
000000000 00000000 29-Jan-2021 00000 00000 00 000.00 Drug Discovery 000 0000
0000000 0000000 06-Nov-2019 00000 00000 00 000.00 Biotechnology
Midatech Pharma 02-Apr-2019 PIPE 000.00 Biotechnology 000 0000
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

China Medical System Subsidiaries (1)

Company Name Industry Location Founded
000 00000000 Corporate Venture Capital Cambridge, United Kingdom 0000
To view China Medical System’s complete subsidiaries history, request access »